Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer

Recruiting now · Not applicable

Conditions studied: Breast Cancer

In brief

Breast cancer (BC) is the most frequently diagnosed cancer in women. Systemic cancer treatments are an important contributor to dramatic improvements in the long-term survival of women with BC. However, cancer treatment can lead to cognitive impairment and declines in quality of life in women with BC. Many cancer survivors experience memory and brain function decline following chemotherapy which can last for years. A newer diet pattern, Mediterranean-DASH \[Dietary Approaches to Stop Hypertension\] Intervention for Neurodegenerative Delay (MIND), was shown to help with protecting brain functions. The MIND diet is high in anti-inflammatory nutrients (e.g., omega-3 polyunsaturated fatty acids (PUFAs), carotenoids, B-vitamins, and polyphenols) and limits the intake of brain-unhealthy foods (i.e., butter/margarine, cheese, red meat, fried foods, pastries, and sweets), which may help alleviate negative cognitive outcomes from cancer treatments. This randomized controlled trial aims to investigate the effect of the MIND diet on cognitive functions in women with invasive BC starting systemic therapies.

Key facts

Study ID

NCT05984888

Run by

Ohio State University Comprehensive Cancer Center

People needed

43

Starts

2023-10-26

Expected to finish

2027-12-01

Last updated by the study team

2025-10-03

Who can join

Age: 45 and older, up to 75. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Stage II-IV hormone receptor+, breast cancer diagnosis
• Post-menopausal (defined as at least 1-year post menses, on ovarian suppression medication, or s/p oophorectomy)
• Within 4 weeks before or 12 weeks after starting initial systemic therapies (e.g. chemotherapy, targeted therapies such as CDK4/6 inhibitors, endocrine therapy)
• Ability to access and use internet resources, including video calls using Zoom platform
• English speaking

You may not qualify if…

• History of dementia, stroke, traumatic brain injury, brain metastasis or other conditions that could lead to cognitive impairment
• MIND diet score >8
• Unwilling/unable to eat >2 types of MIND food
• Receiving insulin therapy for diabetes
• Diagnosis of triple negative breast cancer
• Unable to give informed consent.

Where it is running

• Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.